Theresa A Koleck1, Catherine M Bender1, Susan M Sereika2, Gretchen Ahrendt3, Rachel C Jankowitz4, Kandace P McGuire5, Christopher M Ryan6, Yvette P Conley7. 1. School of Nursing, University of Pittsburgh in Pennsylvania. 2. Department of Biostatistics, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh in Pennsylvania. 3. Department of Surgery, Division of Surgical Oncology, in the School of Medicine, University of Pittsburgh in Pennsylvania. 4. Department of Medicine in the School of Medicine, University of Pittsburgh in Pennsylvania. 5. Department of Surgery in the School of Medicine, University of Pittsburgh in Pennsylvania. 6. School of Nursing and in the Department of Psychiatry in the School of Medicine, University of Pittsburgh in Pennsylvania. 7. Department of Human Genetics in the Graduate School of Public Health, University of Pittsburgh in Pennsylvania.
Abstract
PURPOSE/ OBJECTIVES: To examine the role of apolipoprotein E (APOE) genotype in the cognitive function of postmenopausal women with early-stage breast cancer prior to initiation of adjuvant therapy and over time with treatment. DESIGN: Longitudinal, genetic association study. SETTING: Urban university cancer center. SAMPLE: Three cohorts of postmenopausal women: 37 women with breast cancer receiving chemotherapy and anastrozole, 41 women with breast cancer receiving anastrozole alone, and 50 healthy women. METHODS: Cognitive function was evaluated three times during a 12-month period using a comprehensive neuropsychological test battery. Participants were genotyped and classified based on the presence or absence of at least one APOE e4 allele. Multiple linear regression was used to determine if APOE genotype accounted for observed variability in cognitive function data. MAIN RESEARCH VARIABLES: APOE genotype, breast cancer treatment, and cognitive function. FINDINGS: Performance or changes in performance on tasks of executive function, attention, verbal learning and memory, and visual learning and memory were found to be influenced by APOE genotype and/or interactions between APOE genotype and study cohort. CONCLUSIONS: The results indicate that cognitive function in postmenopausal women with breast cancer is modified by APOE genotype and the combination of APOE genotype and treatment. IMPLICATIONS FOR NURSING: APOE genotype, along with other biomarkers, may be used in the future to assist nurses in identifying women with breast cancer most at risk for cognitive decline.
PURPOSE/ OBJECTIVES: To examine the role of apolipoprotein E (APOE) genotype in the cognitive function of postmenopausal women with early-stage breast cancer prior to initiation of adjuvant therapy and over time with treatment. DESIGN: Longitudinal, genetic association study. SETTING: Urban university cancer center. SAMPLE: Three cohorts of postmenopausal women: 37 women with breast cancer receiving chemotherapy and anastrozole, 41 women with breast cancer receiving anastrozole alone, and 50 healthy women. METHODS: Cognitive function was evaluated three times during a 12-month period using a comprehensive neuropsychological test battery. Participants were genotyped and classified based on the presence or absence of at least one APOE e4 allele. Multiple linear regression was used to determine if APOE genotype accounted for observed variability in cognitive function data. MAIN RESEARCH VARIABLES: APOE genotype, breast cancer treatment, and cognitive function. FINDINGS: Performance or changes in performance on tasks of executive function, attention, verbal learning and memory, and visual learning and memory were found to be influenced by APOE genotype and/or interactions between APOE genotype and study cohort. CONCLUSIONS: The results indicate that cognitive function in postmenopausal women with breast cancer is modified by APOE genotype and the combination of APOE genotype and treatment. IMPLICATIONS FOR NURSING: APOE genotype, along with other biomarkers, may be used in the future to assist nurses in identifying women with breast cancer most at risk for cognitive decline.
Entities:
Keywords:
biologic markers; breast neoplasms; cognition; genes
Authors: Heather A Wishart; Andrew J Saykin; Laura A Rabin; Robert B Santulli; Laura A Flashman; Stephen J Guerin; Alexander C Mamourian; Dorothy R Belloni; C Harker Rhodes; Thomas W McAllister Journal: Am J Psychiatry Date: 2006-09 Impact factor: 18.112
Authors: Kerstin Hermelink; Michael Untch; Michael P Lux; Rolf Kreienberg; Thomas Beck; Ingo Bauerfeind; Karin Münzel Journal: Cancer Date: 2007-05-01 Impact factor: 6.860
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Kamal Adel Amin; Basant Mahmoud Mohamed; Mohamed Aly M El-Wakil; Sanaa Omar Ibrahem Journal: J Breast Cancer Date: 2012-09-28 Impact factor: 3.588
Authors: M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel Journal: Ann Oncol Date: 2019-12-01 Impact factor: 32.976
Authors: Catherine M Bender; John D Merriman; Susan M Sereika; Amanda L Gentry; Frances E Casillo; Theresa A Koleck; Margaret Q Rosenzweig; Adam M Brufsky; Priscilla McAuliffe; Yehui Zhu; Yvette P Conley Journal: Oncol Nurs Forum Date: 2018-05-01 Impact factor: 2.172
Authors: Brian D Gonzalez; Heather S L Jim; Margaret Booth-Jones; Brent J Small; Steven K Sutton; Hui-Yi Lin; Jong Y Park; Philippe E Spiess; Mayer N Fishman; Paul B Jacobsen Journal: J Clin Oncol Date: 2015-05-11 Impact factor: 44.544
Authors: Gee Su Yang; Sreelakshmy Kumar; Susan G Dorsey; Angela R Starkweather; Debra Lynch Kelly; Debra E Lyon Journal: Support Care Cancer Date: 2018-10-20 Impact factor: 3.603
Authors: Janette L Vardy; Haryana M Dhillon; Gregory R Pond; Sean B Rourke; Tsegaye Bekele; Corrinne Renton; Anna Dodd; Haibo Zhang; Philip Beale; Stephen Clarke; Ian F Tannock Journal: J Clin Oncol Date: 2015-11-02 Impact factor: 44.544
Authors: Danielle B Tometich; Brent J Small; Judith E Carroll; Wanting Zhai; George Luta; Xingtao Zhou; Lindsay C Kobayashi; Tim Ahles; Andrew J Saykin; Jonathan D Clapp; Heather S L Jim; Paul B Jacobsen; Arti Hurria; Deena Graham; Brenna C McDonald; Neelima Denduluri; Martine Extermann; Claudine Isaacs; Asma Dilawari; James Root; Christine Rini; Jeanne S Mandelblatt Journal: J Pain Symptom Manage Date: 2018-11-23 Impact factor: 3.612
Authors: Marjan Boerma; Catherine M Davis; Isabel L Jackson; Dörthe Schaue; Jacqueline P Williams Journal: Int J Radiat Biol Date: 2021-07-01 Impact factor: 2.694